With the current record market run, small cap biopharmas have kept pace and continue to trend higher, being one of the best sectors for both trading and investing over the past year. With 39 new drugs approved, 2012 showed the…
Tag: scalp trade
Alert: I bought ArQule Inc. $ARQL
ArQule Inc. (ARQL) Price: $2.86 Market Cap: $178.30M My price target opinion into January 13, $4.00 Catalyst: Tivantinib ArQule has advanced into Phase 3 clinical development with its lead product, tivantinib (ARQ 197), an orally available, small molecule that inhibits…